相关实验视频

Updated: Sep 14, 2025

Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue

Primary Microglia Isolation from Mixed Glial Cell Cultures of Neonatal Rat Brain Tissue

Published on: August 15, 2012

抑制TRPV5调节微介导的神经炎症后的状态

Soojin Park¹, Se Hoon Kim², Chul Hoon Kim³

¹Department of Neurology, Graduate School of Medical Science, Brain Korea 21 Project, Yonsei University College of Medicine, Seoul, Republic of Korea.

|July 25, 2025

概括

针对大脑中的TRPV5通道可以减少神经炎症和微质激活,为提供了一种新的治疗策略. 这种方法可能有助于预防进一步的神经病理损伤.

科学领域:

神经科学是一个神经科学.
免疫学免疫学免疫学
药理学药理学是指药理学的学科.

背景情况:

神经炎症,涉及质激活和炎症媒介,是病理生理学的核心.
识别减少神经炎症的因素对于开发有效的疗法至关重要.
暂时受体潜在化物5 (TRPV5) 在等神经疾病中的作用在很大程度上是未知的.

研究的目的:

研究TRPV5在相关神经炎症中的作用.
确定TRPV5抑制是否可以减弱模型中的微质激活和随后的炎症反应.

主要方法:

在动物中使用了皮洛卡尔诱导的状态 (PCSE) 模型.
研究了海马体中TRPV5的表达,特别是在微质细胞中.
在LPS刺激的初级微质细胞和PCSE模型中使用econazole药理上抑制TRPV5.
评估了微质激活,AKT/NF-κB信号传递,NLRP3炎症酶活性和促炎细胞因子的产生.

主要成果:

在PCSE模型的海马中,TRPV5表达被上调,主要是在激活的微质中.
以埃可纳为媒介的TRPV5抑制将LPS刺激的微质转移到静止状态.
抑制TRPV5抑制了AKT/NF-κB信号传递,并降低了NLRP3炎症酶的活性.
在PCSE模型中,TRPV5的抑制降低了前炎性细胞因子的产生和海马微质激活.

结论:

TRPV5在调节中的微质激活和神经炎症方面发挥着重要作用.
向TRPV5可以在的次急性阶段抑制微质衍生的神经炎症.
抑制TRPV5呈现出一种潜在的新疗法策略,用于管理进展中的神经炎症.

关键词:

在 TRPV5 中.埃科纳 (ECONAZOLE) 是一种可怕的药物.微质细胞中的微质细胞神经炎症是一种神经炎症.状态性的状态

更多相关视频

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Isolation of Cortical Microglia with Preserved Immunophenotype and Functionality From Murine Neonates

Published on: January 30, 2014

Assessing Microglial Phagocytosis of Myelin Debris in vitro Under Repeated Magnetic Stimulation

Assessing Microglial Phagocytosis of Myelin Debris in vitro Under Repeated Magnetic Stimulation

Published on: June 17, 2025

相关概念视频

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...

Antiepileptic Drugs: Glutamate Antagonists

Antiepileptic Drugs: Glutamate Antagonists

Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...

Antiepileptic Drugs: GABAergic Pathway Potentiators

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...